Page 34 - Read Online
P. 34

Page 16 of 18                 Padoan et al. Vessel Plus 2021;5:41  https://dx.doi.org/10.20517/2574-1209.2021.41

                    media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society.
                    Auris Nasus Larynx 2021;48:2-14.  DOI  PubMed
               41.       Harabuchi Y, Kishibe K, Tateyama K, et al. Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic
                    antibody (ANCA)-associated vasculitis (OMAAV): a retrospective analysis of 235 patients from a nationwide survey in Japan. Mod
                    Rheumatol 2017;27:87-94.  DOI  PubMed
               42.       Girard C, Charles P, Terrier B, et al. Tracheobronchial stenoses in granulomatosis with polyangiitis (Wegener’s): a report on 26
                    cases. Medicine (Baltimore) 2015;94:e1088.  DOI  PubMed  PMC
               43.       Fijolek J, Wiatr E, Gawryluk D, et al. Intratracheal dilation-injection technique in the treatment of granulomatosis with polyangiitis
                    patients with subglottic stenosis. J Rheumatol 2016;43:2042-8.  DOI  PubMed
               44.       Seccia V, Cristofani-Mencacci L, Dallan I, et al. Eosinophilic granulomatosis with polyangiitis and laryngeal involvement: Review of
                    the literature and a cross-sectional prospective experience. J Laryngol Otol 2018;132:619-23.  DOI  PubMed
               45.       Del Pero MM, Jayne D, Chaudhry A, et al. Long-term outcome of airway stenosis in granulomatosis with polyangiitis (Wegener
                    Granulomatosis): An observational study. JAMA Otolaryngol Head Neck Surg 2014;140:1038-44.  DOI  PubMed
               46.       Jordan NP, Verma H, Siddiqui A, et al. Morbidity and mortality associated with subglottic laryngotracheal stenosis in granulomatosis
                    with polyangiitis (Wegener’s granulomatosis): a single-centre experience in the United Kingdom. J Laryngol Otol 2014;128:831-7.
                    DOI  PubMed
               47.       Quinn KA, Gelbard A, Sibley C, et al. Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis.
                    Rheumatology (Oxford) 2019;58:2203-11.  DOI  PubMed  PMC
               48.       Guardiani E, Moghaddas HS, Lesser J, et al. Multilevel airway stenosis in patients with granulomatosis with polyangiitis
                    (Wegener’s). Am J Otolaryngol Head Neck Med Surg 2015;36:361-3.  DOI  PubMed
               49.       Terrier B, Dechartres A, Girard C, et al. Granulomatosis with polyangiitis: Endoscopic management of tracheobronchial stenosis:
                    Results from a multicentre experience. Rheumatology (Oxford) 2015;54:1852-7.  DOI  PubMed
               50.       Alam DS, Rahul S, Raj S, et al. Upper airway manifestations of granulomatosis with polyangiitis. Cleve Clin J Med 2012;79:16-21.
                    DOI  PubMed
               51.       Zycinska K, Wardyn K, Zielonka TM, et al. Subglottic and tracheal stenosis due to Wegener’s granulomatosis. Adv Exp Med Biol
                    2013;755:221-4.  DOI  PubMed
               52.       Church AC, Goldsmith K, Sivasothy P. Aspiration and development of subglottic stenosis in patients with Wegeners granulomatosis.
                    J Laryngol Otol 2010;124:393-6.  DOI  PubMed
               53.       Gluth  MB,  Shinners  PA,  Kasperbauer  JL.  Subglottic  stenosis  associated  with  Wegener’s  granulomatosis.  Laryngoscope
                    2003;113:1304-7.  DOI  PubMed
               54.       Marroquín-Fabián E, Ruiz N, Mena-Zúñiga J, et al. Frequency, treatment, evolution, and factors associated with the presence of
                    tracheobronchial stenoses in granulomatosis with polyangiitis. Retrospective analysis of a case series from a single respiratory
                    referral center. Semin Arthritis Rheum 2019;48:714-9.  DOI  PubMed
               55.       Sharma A, Deshmukh S, Dabholkar J. ENT manifestations of Wegeners granulomatosis. Otolaryngol Pol 2013;67:257-60.  DOI
                    PubMed
               56.       Langford CA, Sneller MC, Hallahan CW, et al. Clinical features and therapeutic management of subglottic stenosis in patients with
                    Wegener’s granulomatosis. Arthritis Rheum 1996;39:1754-60.  DOI  PubMed
               57.       Martinez Del Pero M, Rasmussen N, Chaudhry A, et al. Structured clinical assessment of the ear, nose and throat in patients with
                    granulomatosis with polyangiitis (Wegener’s). Eur Arch Otorhinolaryngol 2013;270:345-54.  DOI  PubMed
               58.       Taylor SC, Clayburgh DR, Rosenbaum JT, Schindler JS. Clinical manifestations and treatment of idiopathic and Wegener
                    granulomatosis-associated subglottic stenosis. JAMA Otolaryngol Head Neck Surg 2013;139:76-81.  DOI  PubMed
               59.       Nico MMS, Pinto NT, Lourenço SV. From strawberry gingivitis to palatal perforation: The clinicopathological spectrum of oral
                    mucosal lesions in granulomatosis with polyangiitis. J Oral Pathol Med 2020;49:443-9.  DOI  PubMed
               60.       Xing X, Zhang T, Wang X. Pediatric Wegener’s granulomatosis with oral ulcers and progressive periodontitis: a case report. Oral
                    Surg Oral Med Oral Pathol Oral Radiol Endod 2011:112.  DOI  PubMed
               61.       Knight JM, Hayduk MJ, Summerlin DJ, et al. “Strawberry” gingival hyperplasia: a pathognomonic mucocutaneous finding in
                    Wegener granulomatosis. Arch Dermatol 2000;136:171-3.  DOI  PubMed
               62.       Eufinger H, Machtens E, Akuamoa-Boateng E. Oral manifestations of Wegener’s granulomatosis. Review of the literature and report
                    of a case. Int J Oral Maxillofac Surg 1992;21:50-3.  DOI  PubMed
               63.       Hernández G, Serrano C, Porras L, et al. Strawberry-like gingival tumor as the first clinical sign of Wegener’s granulomatosis. J
                    Periodontol 2008;79:1297-303.  DOI  PubMed
               64.       Hanisch M, Fröhlich LF, Kleinheinz J. Gingival hyperplasia as first sign of recurrence of granulomatosis with polyangiitis
                    (Wegener’s granulomatosis): case report and review of the literature. BMC Oral Health 2016;17:33.  DOI  PubMed  PMC
               65.       Trimarchi M, Bondi S, Della Torre E, Terreni MR, Bussi M. Palate perforation differentiates cocaine-induced midline destructive
                    lesions from granulomatosis with polyangiitis. Acta Otorhinolaryngol Ital 2017;37:281-5.  DOI  PubMed  PMC
               66.       Nelson RE, Hildrew DM, Deblieux T, et al. Wegener’s Granulomatosis presenting as a parapharyngeal mass. J Louisiana State Med
                    Soc Off organ Louisiana State Med Soc 2016;168:60-2.  PubMed
               67.       Lee PY, Adil EA, Irace AL, et al. The presentation and management of granulomatosis with polyangiitis (Wegener’s Granulomatosis)
                    in the pediatric airway. Laryngoscope 2017;127:233-40.  DOI  PubMed
               68.       Shenavandeh S, Petramfar P. Three atypical manifestations of granulomatosis with polyangiitis: lateral medullary syndrome, anterior
                    cheek mass and melting scleritis of eye. Reumatologia 2017;55:145-50.  DOI  PubMed  PMC
   29   30   31   32   33   34   35   36   37   38   39